Entrada Therapeutics, Inc. - TRDA
Officer
President, Research & Develop.
Direct Buys
0
$0
0
Shares
Direct Sells
13
($824,288)
-43,299
Shares
Indirect Buys
0
$0
0
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
12/03/2024
10b5-1
|
12/03/2024 |
Sell
|
-11,703 @ $20.15
|
($235,786) | 144,997 (-7.47%) | Direct |
|
12/02/2024
10b5-1
|
12/03/2024 |
Sell
|
-4,088 @ $20.26
|
($82,834) | 156,700 (-2.54%) | Direct |
|
11/29/2024
10b5-1
|
12/03/2024 |
Sell
|
-100 @ $20.00
|
($2,000) | 160,788 (-0.06%) | Direct |
|
11/13/2024
10b5-1
|
11/13/2024 |
Sell
|
-2,700 @ $20.04
|
($54,109) | 160,888 (-1.65%) | Direct |
|
11/11/2024
10b5-1
|
11/13/2024 |
Sell
|
-1,409 @ $20.01
|
($28,191) | 163,588 (-0.85%) | Direct |
|
11/06/2024
10b5-1
|
11/06/2024 |
Sell
|
-12,299 @ $18.85
|
($231,776) | 164,997 (-6.94%) | Direct |
|
11/05/2024
10b5-1
|
11/06/2024 |
Sell
|
-5,171 @ $18.18
|
($94,006) | 177,296 (-2.83%) | Direct |
|
11/04/2024
10b5-1
|
11/06/2024 |
Sell
|
-749 @ $18.02
|
($13,498) | 182,467 (-0.41%) | Direct |
|
10/16/2024
10b5-1
|
10/18/2024 |
Sell
|
-600 @ $18.00
|
($10,800) | 183,216 (-0.33%) | Direct |
|
09/09/2024
10b5-1
|
09/10/2024 |
Sell
|
-2,642 @ $15.09
|
($39,862) | 183,816 (-1.42%) | Direct |
|
09/06/2024
10b5-1
|
09/10/2024 |
Sell
|
-600 @ $15.24
|
($9,141) | 186,458 (-0.32%) | Direct |
|
07/15/2024
10b5-1
|
07/16/2024 |
Sell
|
-638 @ $18.00
|
($11,484) | 188,814 (-0.34%) | Direct |
|
07/12/2024
10b5-1
|
07/16/2024 |
Sell
|
-600 @ $18.00
|
($10,800) | 189,452 (-0.32%) | Direct |